Peptide therapy has moved out of the research lab and into men's health clinics, including here in Bangkok. The interest is understandable. Peptides are marketed for almost everything a busy man worries about as he ages: stubborn belly fat, a nagging tendon, poor sleep, flat libido, slow recovery from the gym. Some of that interest is backed by reasonable science. A lot of it is hype, and some of it is frankly unsafe when peptides are bought as grey-market "research chemicals" and injected without supervision.
This guide is written to help you tell the difference. It explains what peptides actually are, which ones have meaningful evidence in men, what a supervised protocol costs in Bangkok in both Thai baht and US dollars, who is and is not a candidate, the real risks, and how to choose a clinic that will not cut corners. The aim is a conservative, honest picture rather than a sales pitch.
One point up front, because it matters: peptide therapy is a prescription medical treatment. It requires a consultation, a review of your history and usually blood work, and ongoing monitoring. Nothing in this article is a recommendation to start a specific peptide, and none of it replaces a conversation with a doctor who has examined you.
What peptides actually are
Peptides are short chains of amino acids, usually somewhere between two and fifty units long. Your body makes thousands of them, and they work as signalling molecules. Rather than acting as building blocks the way larger proteins do, peptides carry instructions: telling cells to grow, to repair, to release a hormone, or to quiet an immune response. Insulin is a peptide. So is the growth-hormone-releasing hormone your own hypothalamus produces.
Therapeutic peptides are synthetic versions designed to copy or amplify one of these natural signals for a specific goal. Because they tend to act on a narrow target, the appeal is precision: in theory, you nudge one pathway without flooding the whole system the way a blunt hormone dose might. In practice, that precision is only as good as the evidence behind the particular peptide, and the evidence varies enormously from one molecule to the next.
It helps to hold two categories in your head. A small number of peptides are approved medicines with regulatory review behind them. The much larger group is research-stage: promising in the lab or in animals, sometimes in early human studies, but not approved for the use being marketed. Most of what you will see advertised in men's clinics, in Bangkok and elsewhere, falls into that second group and is prescribed off-label.
Which peptides are used in men's health
Below are the peptides you are most likely to be offered or to read about. The descriptions reflect where the evidence sits today, not where marketing claims it sits.
Growth-hormone-axis peptides (sermorelin, CJC-1295, ipamorelin, tesamorelin)
These peptides act on the growth-hormone axis. Instead of injecting growth hormone directly, they prompt your own pituitary to release more of it. Sermorelin is a 29-amino-acid analogue of growth-hormone-releasing hormone and has been studied as a way to support endogenous growth-hormone output in adults [1]. CJC-1295 and ipamorelin are often combined to produce a similar pulsed release. Men are drawn to this group for sleep quality, recovery, and body composition.
Tesamorelin is the standout because it is genuinely FDA-approved, specifically for reducing excess visceral (deep abdominal) fat in people with HIV-associated lipodystrophy, where randomized trials showed a selective reduction in visceral fat [2]. That approval is narrow. Using tesamorelin or any GH-axis peptide purely as an anti-aging or fat-loss tool in an otherwise healthy man is off-label, and the broader evidence here calls for caution: a systematic review of growth hormone in healthy older adults found only modest changes in body composition alongside a meaningfully higher rate of side effects, and concluded it should not be used as anti-aging therapy [3]. Peptides that raise growth hormone indirectly are not identical to growth hormone, but that review is a useful reality check on the "more GH equals younger" story.
BPC-157 and tissue-repair peptides (BPC-157, TB-500, GHK-Cu)
BPC-157 ("body protection compound") is the peptide men ask about most for injuries. Animal research has shown it can accelerate healing of tendon, ligament, gut lining, and other tissues, including transected Achilles tendon in rats [4]. That is real and interesting science. It is also, almost entirely, preclinical. BPC-157 is not an approved drug anywhere, robust human trials are lacking, and the marketing routinely outruns the data. TB-500 (a thymosin beta-4 fragment) and copper peptide GHK-Cu sit in a similar position: plausible mechanisms, thin human evidence.
PT-141 (bremelanotide)
PT-141, or bremelanotide, is different from the erectile-dysfunction tablets most men know. PDE5 inhibitors such as sildenafil work on blood flow in the penis. Bremelanotide is a melanocortin receptor agonist that acts centrally, in the brain, on the pathways that drive desire and arousal [5]. It is FDA-approved, but for acquired hypoactive sexual desire disorder in premenopausal women, on the strength of two randomized Phase 3 trials; its use in men for libido or erectile concerns is off-label [6]. The preclinical work mapping this central, melanocortin-mediated pathway of sexual response underpins why the drug is being explored across sexes [5]. The most common side effects in trials were nausea, flushing, and headache [6].
If your main concern is erections, peptides are usually not the first or best tool. It is worth understanding the difference between erectile dysfunction and low libido first, because the right treatment depends on which problem you actually have, and proven options such as ED medication or shockwave therapy often make more sense.
GLP-class peptides for weight (semaglutide, tirzepatide, retatrutide)
The GLP-1 and dual/triple-agonist peptides used for weight loss are technically peptides too, and some clinics fold them into a "peptide menu." We treat them as their own category because the evidence and regulatory status are stronger and quite different. If weight is your goal, the dedicated guide on weight-loss medication in Bangkok is more relevant than this page.
Peptide therapy costs in Bangkok (2026)
Pricing depends on the specific peptide, the dose, how many vials your protocol needs per month, and whether consultation and monitoring are bundled in. The figures below are indicative ranges drawn from Bangkok clinics in 2026 and the prices we see for doctor-supervised, pharmacy-sourced peptides. Treat them as a guide and confirm exact numbers at consultation, because a personalised protocol can sit above or below these bands.
The right-hand column is the part medical-tourism patients care about most: what an equivalent supervised program tends to cost in the US or UK. Bangkok is frequently 40-60% cheaper for comparable, physician-led care, largely because consultation and compounding costs are lower, not because the peptides themselves are different.
Item | Bangkok (THB) | Bangkok (USD approx.) | Typical US / UK supervised | Indicative saving |
Initial consultation | 1,000-2,500 | 30-70 | 150-400 USD | ~60-80% |
Baseline blood panel (hormones, metabolic) | 3,000-8,000 | 85-230 | 300-800 USD | ~50-70% |
BPC-157 / GHK-Cu / TB-500 (per vial) | 4,400-7,000 | 125-200 | 200-450 USD | ~40-60% |
Sermorelin / CJC-1295 + ipamorelin (per month) | 7,000-14,000 | 200-400 | 350-700 USD | ~40-55% |
PT-141 (per vial) | 5,000-7,000 | 140-200 | 200-500 USD | ~45-60% |
Tesamorelin (per vial / month) | 7,000-14,000 | 200-400 | 500-1,200 USD | ~50-65% |
Typical all-in monthly program (one to two peptides, supervised) | 8,000-25,000 | 230-720 | 600-1,500 USD | ~40-60% |
Follow-up visit (every 4-6 weeks) | 800-2,000 | 25-60 | 100-300 USD | ~60-75% |
USD figures use an approximate rate near 35 THB to 1 USD and will move with the exchange rate. The Bangkok ranges above are indicative; confirm at consult.
What actually drives the cost
A few variables explain most of the spread you will see between clinics and between months:
Which peptide. A simple repair peptide like BPC-157 is far cheaper than a GLP-class agonist such as retatrutide, where graduated dosing can push a single month well above 30,000 THB.
Dose and number of vials. Protocols escalate. A starting dose may use one vial a month; a higher maintenance dose can use two or more.
Source and quality. Peptides from a licensed pharmacy with a certificate of analysis cost more than grey-market vials, and that gap is the price of knowing what is in the bottle. It is not a corner worth cutting.
What is bundled. Some quoted "program" prices include consultation, the injection kit, and follow-ups; others price each line separately. Ask exactly what is included before comparing two clinics.
Monitoring. Responsible care includes periodic review and sometimes repeat bloods. That is a feature, not an upsell, and it is built into the follow-up line above.
If you are weighing peptides against testosterone therapy on cost and fit, the companion piece on TRT versus peptide therapy breaks down the trade-offs directly.
Who peptide therapy may suit, and who it does not
Peptide therapy is evaluated case by case. It is never prescribed simply because a patient asks for a named peptide they read about online.
Profiles a doctor may reasonably consider include adults with a chronic soft-tissue or tendon problem that has not settled with standard care, men with slow post-surgical or post-injury recovery, those with documented age-related decline in growth-hormone markers on testing, or specific, well-characterised sexual-function concerns where central pathways are relevant. Even then, suitability depends on your history, your medications, and your blood work, not on the peptide alone.
There are also people for whom peptide therapy is generally not appropriate, or who need particularly careful screening first:
Anyone with an active or recent cancer, or a strong personal history of hormone-sensitive cancer. Because several peptides influence growth and cell signalling, this is a firm caution and an area where a specialist opinion is essential.
Men who are actively trying to conceive, where hormone-axis manipulation needs careful thought.
People with poorly controlled diabetes or significant cardiovascular, kidney, or liver disease, depending on the peptide.
Anyone on medications that could interact, which is exactly why a full medication review happens before any prescription.
Pregnancy and breastfeeding are clear contraindications (relevant if a partner is involved in shared care decisions).
These lists are not exhaustive, and they are the reason the first step is always a consultation rather than a purchase.
Where the evidence really stands
It is worth being blunt, because a lot of clinics are not. For most peptides used in men's health today, the preclinical and mechanistic science is genuinely promising, but large, long-term human trials are limited or absent. That does not make peptides useless. It does mean the honest framing is "research-stage treatment with a reasonable rationale," not "proven therapy."
A short, fair summary of the current picture looks like this:
Peptide | Main interest in men | Regulatory status | Strength of human evidence |
Tesamorelin | Visceral fat reduction | FDA-approved (HIV lipodystrophy) | Strong for its narrow indication; off-label otherwise |
Bremelanotide (PT-141) | Desire / arousal | FDA-approved (HSDD in women) | Good for that indication; off-label in men |
Sermorelin | GH support, recovery, sleep | Not approved for anti-aging use | Limited; mostly older or diagnostic data |
CJC-1295 / ipamorelin | GH support, body composition | Not approved | Limited human trial data |
BPC-157 | Tendon, ligament, gut repair | Not an approved drug | Preclinical / animal; human data lacking |
TB-500, GHK-Cu | Tissue repair, skin | Not approved as injectables | Preclinical; thin human evidence |
A good clinic will tell you which row a proposed peptide sits in and will not blur an FDA approval for one indication into a promise for a different one.
What results are realistic
Honest expectation-setting is part of safe care. Timelines and magnitude vary by peptide and by person, and outcomes are not guaranteed.
For GH-axis peptides such as sermorelin, men who respond tend to notice changes gradually over weeks to a few months, often starting with sleep and subjective recovery before any change in body composition. The systematic review on growth hormone itself is a useful anchor for scale: even with direct GH, body-composition changes in healthy adults were modest, so expectations for indirect peptides should be measured rather than dramatic [3]. For tissue-repair peptides like BPC-157, the supportive evidence is animal data on faster healing [4]; any human benefit is unproven, and these are best seen as an adjunct to, not a replacement for, proper rehabilitation. For PT-141, trials in women showed a statistically significant but moderate improvement in desire rather than a switch-flip effect [6], and the men's use is off-label.
If after a fair trial and appropriate monitoring a peptide is not delivering, the right move is to stop it. Continuing an expensive treatment that is not working is not conservative care.
Have a question about your treatment?
Message our Bangkok clinic on WhatsApp and a doctor replies within minutes during clinic hours.
Risks and side effects
Peptides are not free of risk, and the risk profile depends heavily on the molecule, the dose, and crucially the source.
Common, usually mild effects reported across peptide protocols include irritation, redness, or swelling at the injection site, transient headache, flushing, fatigue, and water retention. With GH-axis peptides, some men notice tingling or numbness in the hands, joint aches, or fluid retention, which generally ease if the dose is reduced. With PT-141, nausea, flushing, and headache were the most common effects in trials [6].
The more serious risks cluster around quality and the wrong patient. Grey-market peptides bought as "research chemicals" can be underdosed, overdosed, contaminated, or simply not the molecule on the label, and a contaminated injectable can cause serious harm. This is the single biggest avoidable danger in the peptide space. Manipulating the growth-hormone axis also carries theoretical concerns around blood sugar, fluid balance, and the growth of existing tissue, which is why active or prior cancer is treated so cautiously.
Seek urgent medical care if, after any injection, you develop signs of a severe allergic reaction (swelling of the face, lips, or throat, difficulty breathing, widespread hives), chest pain or palpitations, a spreading hot, red, painful area at an injection site with fever (possible infection), sudden severe headache with visual changes, or fainting. These are uncommon, but they are reasons to stop and get assessed rather than to wait.
How to choose a peptide clinic safely
The quality gap between clinics in this space is wide. A few signals separate responsible, doctor-led care from a vendor in a white coat.
Green flags worth looking for:
A real medical consultation, with history-taking, a medication review, and blood work where clinically indicated, before any prescription.
Peptides dispensed by a licensed pharmacy, with a certificate of analysis available on request, never sold as "research chemicals."
A named, qualified doctor responsible for your protocol, and scheduled follow-up every four to six weeks.
Straight talk about regulatory status: which peptides are approved, which are off-label, and what the evidence does and does not show.
A visible clinic licence. In Thailand, clinics operate under a Ministry of Public Health licence (Menscape's is 10101005767), which should be displayed.
Red flags worth walking away from:
Prescribing a peptide by name without examining you or reviewing your history.
No blood work, no follow-up, and no questions about other medications.
Guaranteed or dramatic results, or claims that a peptide "cures" a condition.
Pressure to buy multi-month packages on the first visit.
Vague sourcing, no pharmacy involvement, or vials with no certificate of analysis.
If you want a broader view of how peptides fit alongside other preventive options, the overview of longevity medicine for men and the dedicated advanced blood checkup are sensible companion reads, since good baseline data is where any peptide decision should start.
How a Menscape peptide protocol works
Our approach is deliberately conservative and prescription-only.
Consultation and history review. A doctor reviews your goals, full medical history, and current medications. This is also where unrealistic expectations get reset and where non-peptide options are discussed if they fit you better.
Blood work where indicated. Baseline labs (hormonal and metabolic markers as appropriate) help confirm whether a peptide is sensible and give a reference point for monitoring.
An honest discussion of evidence. We explain what the research supports for your specific situation, including the difference between FDA-approved indications and off-label use, before anything is prescribed.
Prescription and pharmacy sourcing. If a peptide is appropriate, the doctor selects the compound, dose, and cycle length, and the prescription is filled by a licensed pharmacy partner, not a research-chemical vendor.
Monitoring. Follow-up every four to six weeks assesses response and side effects and decides whether to adjust, continue, or stop.
Book a consultation
If you are considering peptide therapy and want a doctor-led, conservative approach rather than an off-the-shelf package, the first step is a consultation at our Chidlom clinic. The visit clarifies whether peptide therapy is a sensible fit for your case, what a realistic protocol and cost would look like, and whether a non-peptide option might serve you better. Peptide therapy at Menscape is prescription-only and always begins with a medical consultation. You can book a consultation or message the clinic to arrange a time that works for you.
Frequently Asked Questions
Is peptide therapy legal in Thailand?
Peptides can be prescribed by a licensed doctor and dispensed through a licensed pharmacy in Thailand. What is not safe or advisable is buying peptides marketed as 'research chemicals' and self-injecting them, since those are unregulated and may be contaminated, mislabelled, or wrongly dosed. At a reputable clinic, peptide therapy is a supervised, prescription-only medical treatment that begins with a consultation.
How much does peptide therapy cost in Bangkok?
A doctor-supervised program typically runs about 8,000-25,000 THB per month, roughly 230-720 USD, depending on the specific peptide, the dose, and how many vials your protocol needs. Individual vials of common repair peptides such as BPC-157 are often around 4,400-7,000 THB. GLP-class weight peptides cost considerably more. These ranges are indicative for 2026 and should be confirmed at consultation, since a personalised protocol can sit above or below them.
Are peptides FDA-approved?
A small number are. Tesamorelin is FDA-approved for reducing visceral fat in HIV-associated lipodystrophy, and bremelanotide (PT-141) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. Most peptides marketed in men's health, including BPC-157, sermorelin, CJC-1295, ipamorelin, and TB-500, are research-stage or prescribed off-label, meaning they are not approved for the use being advertised. A good clinic will tell you exactly which category a proposed peptide falls into.
Are peptides safe?
When prescribed by a doctor, sourced from a licensed pharmacy, and monitored, the common side effects are usually mild, such as injection-site irritation, headache, flushing, or fluid retention. The serious risks cluster around grey-market products, which can be contaminated or mislabelled, and around prescribing to the wrong patient, which is why active or prior cancer and several other conditions require careful screening. Safety depends heavily on supervision and sourcing, not on the peptide alone.
Can peptides help with erectile dysfunction or low libido?
PT-141 (bremelanotide) acts centrally in the brain on desire and arousal pathways, which is different from how erectile-dysfunction tablets work on blood flow. Its approved use is for low desire in women, and use in men is off-label. For most men with erection problems, proven options such as PDE5 medication or shockwave therapy are usually a better first step. The right choice depends on whether your main issue is erections or desire, which a consultation can clarify.
How long before peptides work, and are results guaranteed?
Timelines vary by peptide and by person, and no result is guaranteed. With growth-hormone-axis peptides, men who respond often notice gradual changes over weeks to a few months, frequently starting with sleep and subjective recovery. Tissue-repair peptides are supported mainly by animal data, so any human benefit is unproven and they are best used alongside proper rehabilitation. If a peptide is not delivering after a fair, monitored trial, the right course is to stop it.
Do I need blood tests and a prescription for peptide therapy?
Yes. Responsible peptide therapy starts with a consultation and, where clinically indicated, baseline blood work, and it is always prescription-only. The labs help confirm whether a peptide is sensible for you and provide a reference point for monitoring. Any clinic willing to prescribe a peptide by name without examining you, reviewing your medications, or arranging follow-up should be treated as a warning sign.
Where does Menscape source its peptides?
Prescriptions are filled by a licensed compounding pharmacy partner, and we do not use unregulated research-chemical vendors. Pharmacy sourcing means the product can come with a certificate of analysis confirming identity and purity, which is the single most important quality safeguard in peptide therapy. The cost difference versus grey-market vials reflects exactly that assurance.

/)
/)
/)
/)
/)
/)